Target intelligence / Profile preview

Oxygen transport via physical dissolution in perfluorocarbon phase

Molecular classification
Other
01

Overview

Oxygen transport via physical dissolution in perfluorocarbon phase refers to the artificial delivery of oxygen using perfluorocarbon emulsions (PFCs), which are inert, highly fluorinated organic compounds capable of dissolving large amounts of oxygen due to their chemical structure and Van der Waals interactions. PFC-based oxygen delivery functions fundamentally differently than hemoglobin-mediated oxygen transport: oxygen is carried only in a physically dissolved state (not bound), resulting in a linear relationship between oxygen partial pressure and content. Upon intravenous administration, oxygen-enriched PFCs can pass through microcirculation even where red blood cells are absent or flow is compromised, delivering oxygen to hypoxic tissues by direct diffusion down a concentration gradient. These emulsions have been researched as blood substitutes and artificial oxygen carriers for indications such as emergency resuscitation, stroke, and severe anemia, but not as molecular targets (receptors, enzymes), and thus are not considered therapeutic targets in the standard sense. Key challenges include short vascular half-life, reticuloendothelial clearance, product stability, and issues with clinical translation such as immune response to emulsifying agents and reproducibility. PFCs are not metabolized in vivo and are ultimately exhaled via the lungs.

Other names
Perfluorocarbon-based oxygen carrierArtificial oxygen carrier (AOC) via perfluorocarbonPFC oxygen carrierPFC-based oxygen transportPerfluorocarbon emulsion oxygen delivery
02

Mechanism of action

Physical dissolution and diffusion of oxygen; Facilitated diffusion of oxygen into tissues from perfluorocarbon droplets

03

Biological functions

Oxygen deliveryArtificial oxygen transportTreatment of hypoxiaEnhancement of tissue oxygenation
04

Disease associations

Hypoxic conditions (e.g., stroke, myocardial infarction)Blood loss (hemorrhage, trauma, surgery)Ischemic diseaseSickle cell disease
05

Safety considerations

Uptake by reticuloendothelial system, short intravascular half-lifePotential for immune reaction to emulsifiersClinical translation challenges: colloidal stability, clearance mechanism, and quality controlConcerns with oxygen toxicity at high oxygen partial pressures
06

Interacting drugs

Oxygent (perfluorocarbon-based blood substitute)

3 more in the full profile.

Beyond the preview

Go deeper on Oxygen transport via physical dissolution in perfluorocarbon phase.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oxygen transport via physical dissolution in perfluorocarbon phase.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call